Immunologic and virologic predictors of AIDS-related non-Hodgkin lymphoma in the HAART era

Por Engels, Eric A., Pfeiffer, Ruth M., Landgren, Ola, Moore, Richard D.
Publicado em 2010

Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study

Por Gibson, Todd M., Morton, Lindsay M., Shiels, Meredith S., Clarke, Christina A., Engels, Eric A.
Publicado no AIDS (2014)

Effect of HAART on Incident Cancer and Non-Cancer AIDS Events among Male HIV Seroconverters

Por Shiels, MS, Cole, SR, Wegner, S, Armenian, H, Chmiel, JS, Ganesan, A, Marconi, VC, Martinez-Maza, O, Martinson, J, Weintrob, A, Jacobson, LP, Crum-Cianflone, NF
Publicado em 2008

Does HAART efficacy translate to effectiveness? Evidence for a trial effect.

Por Prema Menezes, William C Miller, David A Wohl, Adaora A Adimora, Peter A Leone, William C Miller, Joseph J Eron
Publicado em 2011-01-01

Does HAART Efficacy Translate to Effectiveness? Evidence for a Trial Effect

Por Menezes, Prema, Miller, William C., Wohl, David A., Adimora, Adaora A., Leone, Peter A., Miller, William C., Eron, Joseph J.
Publicado em 2011

Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Vs. Non-Infected Patients in the HAART Era: Impact of Immunosuppression

Por Bedimo, Roger J., McGinnis, Kathleen A., Dunlap, Melinda, Rodriguez-Barradas, Maria C., Justice, Amy C.
Publicado em 2009

Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals

Por Long, Jessica L., Engels, Eric A., Moore, Richard D., Gebo, Kelly A.
Publicado em 2008

Pattern of cancer risk in persons with AIDS in Italy in the HAART era

Por Dal Maso, L, Polesel, J, Serraino, D, Lise, M, Piselli, P, Falcini, F, Russo, A, Intrieri, T, Vercelli, M, Zambon, P, Tagliabue, G, Zanetti, R, Federico, M, Limina, R M, Mangone, L, De Lisi, V, Stracci, F, Ferretti, S, Piffer, S, Budroni, M, Donato, A, Giacomin, A, Bellù, F, Fusco, M, Madeddu, A, Vitarelli, S, Tessandori, R, Tumino, R, Suligoi, B, Franceschi, S
Publicado em 2009

The Immunological Response of Hiv-Positive Patients Initiating Haart at the Komfo Anokye Teaching Hospital, Kumasi, Ghana

Por Annison, L, Dompreh, A, Adu-Sarkodie, Y
Publicado em 2013

Induction maintenance concept for HAART as initial treatment in HIV infected infants

Por Ghosh, S, Neubert, J, Niehues, T, Adams, O, Morali-Karzei, N, Borkhardt, A, Laws, HJ
Publicado em 2011

Aerobic Fitness Levels and Validation of a Non-Exercise VO(2max) Prediction Equation for HIV-Infected Patients on HAART

Por Sullivan, Katherine, Shikuma, Cecilia M., Chow, Dominic, Cornelius, Elizabeth, Romine, Rebecca K., Lindsey, Rachel A., Stickley, Christopher D., Kimura, Iris F., Hetzler, Ronald K.
Publicado no HIV Clin Trials (2014)

Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients

Por Frassetto, L.A., Floren, L.C., Barin, B., Browne, M., Wolfe, A.R., Roland, M.E., Stock, P.G., Carlson, L., Christians, U., Benet, L.Z.
Publicado em 2013

Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial

Por Gori, A, Rizzardini, G, van't Land, B, Amor, K B, van Schaik, J, Torti, C, Quirino, T, Tincati, C, Bandera, A, Knol, J, Benlhassan-Chahour, K, Trabattoni, D, Bray, D, Vriesema, A, Welling, G, Garssen, J, Clerici, M
Publicado em 2011

Self-Perception of Body Fat Changes and HAART Adherence in the Women’s Interagency HIV Study

Por Plankey, Michael, Bacchetti, Peter, Jin, Chengshi, Grimes, Barbara, Hyman, Charles, Cohen, Mardge, Howard, Andrea A., Tien, Phyllis C.
Publicado em 2008

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study

Por Dauby, Nicolas, De Wit, Stéphane, Delforge, Marc, Necsoi, Valentina Coca, Clumeck, Nathan
Publicado em 2011

The association between food insecurity and mortality among HIV-infected individuals on HAART

Por Weiser, Sheri D., Fernandes, Kimberly A., Brandson, Eirikka K., Lima, Viviane D., Anema, Aranka, Bangsberg, David R., Montaner, Julio S., Hogg, Robert S.
Publicado em 2009

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

Por Franceschi, S, Lise, M, Clifford, G M, Rickenbach, M, Levi, F, Maspoli, M, Bouchardy, C, Dehler, S, Jundt, G, Ess, S, Bordoni, A, Konzelmann, I, Frick, H, Dal Maso, L, Elzi, L, Furrer, H, Calmy, A, Cavassini, M, Ledergerber, B, Keiser, O
Publicado em 2010

Inferiority of IL-2 alone versus IL-2 plus HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial

Por Porter, Brian O., Anthony, Kara B., Shen, Jean, Hahn, Barbara, Keh, Chris E., Maldarelli, Frank, Blackwelder, William C., Lane, H. Clifford, Kovacs, Joseph A., Davey, Richard T., Sereti, Irini
Publicado no AIDS (2009)

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study

Por Okulicz, Jason F, Grandits, Greg A, French, Jacqueline A, George, Jomy M, Simpson, David M, Birbeck, Gretchen L, Ganesan, Anuradha, Weintrob, Amy C, Crum-Cianflone, Nancy, Lalani, Tahaniyat, Landrum, Michael L
Publicado em 2011

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART

Por Adler, David H., Kakinami, Lisa, Modisenyane, Tebogo, Tshabangu, Nkeko, Mohapi, Lerato, De Bruyn, Guy, Martinson, Neil A., Omar, Tanvier
Publicado em 2012